Furthermore, higher Bcl-xL expression was also associated with poorer OS and PFS in both the learning and validation cohorts (Fig. 6c, d), which was consistent with there being higher PGAM5 levels in the same HCC specimens. The gene discussed is BCL2L1; the disease is hepatocellular carcinoma.